STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
Status:
Recruiting
Trial end date:
2024-06-03
Target enrollment:
Participant gender:
Summary
Phase 2b/3 double blind, randomized, placebo-controlled trial to assess safety and efficacy
of SLS-005 (trehalose injection, 90.5 mg/mL for intravenous infusion) for the treatment of
adults with spinocerebellar ataxia).